Wszystkie produkty 
- PHOENIX Europe | 100 μg | 001-01 | ACTH (Human)
- PHOENIX Europe | 500 μg | 001-03 | [D-Arg8]-ACTH (4-10) (Human)
- PHOENIX Europe | 200 μg | 001-06 | ACTH (1-24) (Human, Rat, Mouse, Porcine)
- PHOENIX Europe | 200 μg | 001-08 | Survivin / Apoptosis Inhibitor (17-34) (Human)
- PHOENIX Europe | 200 μg | 001-09 | Survivin / Apoptosis Inhibitor (84-110) (Human)
- PHOENIX Europe | 200 μg | 001-11 | Survivin 2B (80-88) (Human)
- PHOENIX Europe | 200 μg | 001-12 | ACTH (7-38) / Corticotropin Inhibiting Peptide (CIP) (Human)
- PHOENIX Europe | 200 μg | 001-14 | ACTH (18-39) / CLIP (Human)
- PHOENIX Europe | 1 mg | 001-16 | AdipoRon / Adiponectin Receptor Antagonist
- PHOENIX Europe | 500 μg | 001-17 | IDE Inhibitor, 6bK
- PHOENIX Europe | 100 μg | 001-18 | GLP-1 Enhancer, N55
- PHOENIX Europe | 500 μg | 001-20 | ACTH (22-39) / β-Cell Tropin
- PHOENIX Europe | 200 μg | 001-21 | ACTH (Rat, Mouse)
- PHOENIX Europe | 200 μg | 001-23 | Adiponectin Receptor Type 2 (Adipo R2) (374-386) (Human, Equine)
- PHOENIX Europe | 100 μg | 001-24 | [Cys0]-GPR-38-A (384-412)
- PHOENIX Europe | 100 μg | 001-26 | CORS 26 (43-66)
- PHOENIX Europe | 100 μg | 001-27 | [Cys0]-GPR-134 (301-324) (Human)
- PHOENIX Europe | 100 μg | 001-28 | [Cys0]-CORS 26 (88-111)
- PHOENIX Europe | 100 μg | 001-29 | [Cys0]-GPR-38-A (390-412) / Motilin Receptor (Human)
- PHOENIX Europe | 100 μg | 001-30 | [Cys0]-CORS 26 (222-246)
- PHOENIX Europe | 100 μg | 001-31 | GPR-99 (319-337) (Human)
- PHOENIX Europe | 100 μg | 001-32 | [Cys0]-GPR-91 (308-330) (Human)
- PHOENIX Europe | 100 μg | 001-33 | GlyR alpha3 (383-406) (Human)
- PHOENIX Europe | 100 μg | 001-34 | GPCR 154, Isoform B (357-377) (Human)
- PHOENIX Europe | 100 μg | 001-35 | [Cys0]-GPCR-56 (658-693) (Human)
- PHOENIX Europe | 100 μg | 001-36 | GPRA (341-359)
- PHOENIX Europe | 100 μg | 001-37 | CGRP Type 1 Receptor (436-461) (Human)
- PHOENIX Europe | 100 μg | 001-38 | Calcitonin Receptor-Like Receptor (CALCRL) (434-465) (Salmon)
- PHOENIX Europe | 100 μg | 001-39 | GPR-41 (320-346) (Human)
- PHOENIX Europe | 100 μg | 001-40 | [Cys0]-AMP-activated Protein Kinase (AMPK) (226-254) (Human)
- PHOENIX Europe | 100 μg | 001-41 | GPCR-2037, C-terminal (Mouse)
- PHOENIX Europe | 100 μg | 001-42 | GPR-103 / SP 9155 (401-431) (Human)
- PHOENIX Europe | 100 μg | 001-43 | Adiponectin Receptor Type 2 (Adipo R2) (4-39) (Human)
- PHOENIX Europe | 100 μg | 001-44 | Adiponectin Receptor Type 1 (Adipo R1) (357-375) (Human)
- PHOENIX Europe | 100 μg | 001-45 | Adiponectin Receptor Type 1 (Adipo R1) (41-65) (Human)
- PHOENIX Europe | 100 μg | 001-46 | SP 9155 (401-433) (Mouse)
- PHOENIX Europe | 100 μg | 001-47 | HM74 (357-387)
- PHOENIX Europe | 100 μg | 001-48 | CG 7285, C-terminal
- PHOENIX Europe | 100 μg | 001-49 | CG 13702, C-terminal
- PHOENIX Europe | 100 μg | 001-50 | AUF-1 (151-199) (Human)
- PHOENIX Europe | 100 μg | 001-51 | [Cys0]-Survivin (123-142) / Apoptosis Inhibitor
- PHOENIX Europe | 100 μg | 001-52 | [Cys0]-Neuropeptide F Receptor (457-481)
- PHOENIX Europe | 100 μg | 001-53 | LGR7 (735-757) (Human)
- PHOENIX Europe | 100 μg | 001-54 | [Cys0]-LGR8 (737-754) (Human)
- PHOENIX Europe | 100 μg | 001-55 | GPR-73a (356-393) (Human)
- PHOENIX Europe | 100 μg | 001-56 | GPR-7 (310-328) (Human)
- PHOENIX Europe | 100 μg | 001-57 | GPR-8 (319-333) (Human)
- PHOENIX Europe | 100 μg | 001-58 | Neuropeptide FF Receptor 1 (NPFF-1R) (185-203) (Human)
- PHOENIX Europe | 100 μg | 001-59 | Neuropeptide FF Receptor 2 (NPFF-2R) (291-308) (Human)
- PHOENIX Europe | 100 μg | 001-60 | Neuropeptide FF Receptor 1 (NPFF-1R) (414-430) (Human)